Born on 27 September 1958 in the Indian state of Maharashtra, K. V. Subba Rao graduated in science from the University of Pune and before starting his career by joining Malti-Chem Research Centre, Baroda, he secured his master's degree also from the same university in 1979.[8] Subsequently, he did his doctoral studies under Sukhdev at Maharaja Sayajirao University of Baroda[2] and moved to Johns Hopkins University in 1983 for his post-doctoral studies at their Division of Environmental Chemistry where he worked with Miles R. Chedekel.[6] After working for two years there, he joined the laboratory of Fred C. Fox at the University of California and worked there for three more years. Returning to India in 1988, he joined the International Centre for Genetic Engineering and Biotechnology where he held different positions as that of a research scientist (1988–91) and research assistant (1991–94) and was the Group Leader of the Immunology Group (1994-2015).[8]
During his post-doctoral days in the US, Rao's researches were focused on the synthesis of melanin pigments as well as on the carcinoma cells of human breast and the cross-talk between growth factor and steroid receptors.[6] The group led by him is credited with the discovery of a novel subset of IgD receptors on 'naive' B lymphocytes which helped in a wider understanding of antigen-specific B cell selection and amplification.[9] Later, furthering his earlier researches, he worked on designing new synthetic peptide vaccines for Hepatitis B which were reported to generate high immunogenicity in humans. He is also known to have contributed in the pathogenesisofMycobacterium tuberculosis and in the diagnostics of HIV/AIDS.[6] It was during his period with Virander Singh Chauhan and Ranjan Kumar Nanda at ICGEB, the group developed an electronic nose, a urine test, to monitor the progress of tuberculosis therapy.[10] His current assignments are on the study of plasticity controlling mechanisms in receptor-initiated signaling pathways based on the systems level analysis of the antigen receptor-dependent signal transduction network.[11] His research findings have been published as a number of articles;[note 1] .[12]
He chaired U-EXCEL 2012, a task force of the Department of Biotechnology, for the North-eastern region of India[13] and is a member of the Science and Engineering Research Board of the Department of Science and Technology.[14] He is associated with the Institute of Life Sciences, Bhubaneswar as a member of its Scientific Advisory Committee[15] and has delivered lectures on its behalf.[16] He has also served as the president of the Indian Immunology Society from 2004 to 2008.[6]
^"Extraordinary gazette"(PDF). (Science and Engineering Research Board, Department of Science and Technology. 24 August 2014. Retrieved 12 October 2016.
